Page last updated: 2024-08-22

misonidazole and Genital Neoplasms, Female

misonidazole has been researched along with Genital Neoplasms, Female in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballon, SC; Coleman, CN; Halsey, J; Hirst, VK; Howes, AE; Martinez, A1
Brady, LW; Phillips, TL; Wasserman, TH1
Kleine, W; Ladner, HA; Nagy, D; Stange, S1
Kogelnik, HD; Mamoli, B; Reinartz, G; Seitz, W; Stark, H; Szepesi, T; Wessely, P; Wurst, F1
Ash, DV; Bugden, RD; Smith, MR1

Reviews

1 review(s) available for misonidazole and Genital Neoplasms, Female

ArticleYear
The potential for radiation sensitizers and radiation protectors combined with radiation therapy in gynecologic cancer.
    Cancer, 1981, Jul-15, Volume: 48, Issue:2 Suppl

    Topics: Amifostine; Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Female; Genital Neoplasms, Female; Humans; Misonidazole; Oxygen; Radiation-Protective Agents; Radiation-Sensitizing Agents; Random Allocation

1981

Trials

1 trial(s) available for misonidazole and Genital Neoplasms, Female

ArticleYear
The potential for radiation sensitizers and radiation protectors combined with radiation therapy in gynecologic cancer.
    Cancer, 1981, Jul-15, Volume: 48, Issue:2 Suppl

    Topics: Amifostine; Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Female; Genital Neoplasms, Female; Humans; Misonidazole; Oxygen; Radiation-Protective Agents; Radiation-Sensitizing Agents; Random Allocation

1981

Other Studies

4 other study(ies) available for misonidazole and Genital Neoplasms, Female

ArticleYear
The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncology.
    Gynecologic oncology, 1984, Volume: 18, Issue:1

    Topics: Adult; Aged; Drug Evaluation; Female; Genital Neoplasms, Female; Humans; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles; Oxygen; Palliative Care; Peripheral Nervous System Diseases; Radiation-Sensitizing Agents

1984
[Treatment with misonidazole and high voltage irradiation of xenotransplanted human carcinomas in nu/nu mice with thymic aplasia].
    Strahlentherapie, 1982, Volume: 158, Issue:8

    Topics: Animals; Cobalt Radioisotopes; Female; Genital Neoplasms, Female; Humans; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Ovarian Neoplasms; Radiotherapy, High-Energy; Uterine Cervical Neoplasms; Uterine Neoplasms

1982
[Clinical experience with daily doses of misonidazole (author's transl)].
    Strahlentherapie, 1980, Volume: 156, Issue:11

    Topics: Adult; Aged; Breast Neoplasms; Female; Genital Neoplasms, Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Nervous System; Nitroimidazoles; Time Factors

1980
Distribution of misonidazole in human tumours and normal tissues.
    British journal of cancer, 1979, Volume: 39, Issue:5

    Topics: Brain Neoplasms; Breast Neoplasms; Female; Genital Neoplasms, Female; Humans; Male; Misonidazole; Neoplasms; Nitroimidazoles; Thyroid Diseases; Tissue Distribution; Urinary Bladder Neoplasms

1979